Acute and chronic demyelinating polyneuropathy post AstraZeneca Covid-19 vaccine

With the rollout of worldwide Covid-19 vaccination programmes, there have been reports of  potential neurological complications which may be attributable to the vaccines. These include cerebral venous sinus thrombosis (CVST)1, which appears to be a complication of thrombosis with  thrombocytopenia syndrome (TTS). This has been documented as a rare complication of the  AstraZeneca and Ad26.COV2.S (Janssen) Covid-19 vaccines </p

Acute and chronic demyelinating polyneuropathy post AstraZeneca Covid-19 vaccine

With the rollout of worldwide Covid-19 vaccination programmes, there have been reports of  potential neurological complications which may be attributable to the vaccines. These include cerebral venous sinus thrombosis (CVST)1, which appears to be a complication of thrombosis with  thrombocytopenia syndrome (TTS). This has been documented as a rare complication of the  AstraZeneca and Ad26.COV2.S (Janssen) Covid-19 vaccines </p